ARTHX
Price
$27.12
Change
+$0.07 (+0.26%)
Updated
Dec 3 closing price
Net Assets
201.72M
RNPCX
Price
$71.95
Change
+$0.37 (+0.52%)
Updated
Dec 3 closing price
Net Assets
162.64B
Interact to see
Advertisement

ARTHX vs RNPCX

Header iconARTHX vs RNPCX Comparison
Open Charts ARTHX vs RNPCXBanner chart's image
Artisan Global Equity Investor
Price$27.12
Change+$0.07 (+0.26%)
VolumeN/A
Net Assets201.72M
American Funds New Perspective R3
Price$71.95
Change+$0.37 (+0.52%)
VolumeN/A
Net Assets162.64B
ARTHX vs RNPCX Comparison Chart in %
View a ticker or compare two or three
VS
ARTHX vs. RNPCX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTHX is a Hold and RNPCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 163B vs. ARTHX (202M). ARTHX pays higher dividends than RNPCX: ARTHX (0.52) vs RNPCX (0.21). ARTHX was incepted earlier than RNPCX: ARTHX (16 years) vs RNPCX (24 years). ARTHX (1.35) is less costly to investors than RNPCX (1.06). ARTHX is a more actively managed with annual turnover of: 136.55 vs. RNPCX (24.00). RNPCX has a lower initial minimum investment than ARTHX: RNPCX (250) vs ARTHX (1000). ARTHX annual gain was more profitable for investors over the last year : 25.51 vs. RNPCX (11.50). ARTHX (23.00) and RNPCX (22.60) have equivalent 5 years return.
ARTHXRNPCXARTHX / RNPCX
Total Expense Ratio1.351.06127%
Annual Report Gross Expense Ratio1.351.06127%
Fund Existence16 years24 years-
Gain YTD42.58719.777215%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets202M163B0%
Annual Yield % from dividends0.520.21244%
Returns for 1 year25.5111.50222%
Returns for 3 years63.5943.97145%
Returns for 5 years23.0022.60102%
Returns for 10 years69.8590.0378%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATNM1.450.07
+5.07%
Actinium Pharmaceuticals
AXSM147.815.72
+4.03%
Axsome Therapeutics
ARLO14.270.38
+2.74%
Arlo Technologies
TLSI6.43-0.02
-0.31%
TriSalus Life Sciences
MNSBP24.85-0.12
-0.50%
MainStreet Bancshares